Description: FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
Home Page: www.fdcindia.com
142-48, Swami Vivekananda Road
Mumbai,
400102
India
Phone:
91 22 3071 9100
Officers
| Name | Title |
|---|---|
| Dr. Nandan Mohan Chandavarkar | Joint MD & Exec. Director |
| Mr. Mohan Anand Chandavarkar | MD & Director |
| Mr. Sanjay B. Jain | Chief Financial Officer |
| Ms. Varsharani Katre C.S. | Compliance Officer & Company Sec. |
| Mr. Ameya Ashok Chandavarkar | CEO of International Bus. & Exec. Director |
| Mr. Ashok Anand Chandavarkar | Whole Time Director |
| Ms. Nomita Ramdas Chandavarkar | Whole Time Director |
| Mr. Dilip V. Karnik | Pres of Technical & Operations |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 18.5429 |
| Price-to-Book MRQ: | 3.2706 |
| Price-to-Sales TTM: | 4.3249 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |